Skip to main content

Ocu-Sul 30 Side Effects

Generic name: sulfacetamide sodium ophthalmic

Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.

Note: This document provides detailed information about Ocu-Sul 30.

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension Side Effects associated with sulfacetamide sodium ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Ocu-Sul 30.

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension.

Side effects include:

Local irritation, transient stinging or burning.

For Healthcare Professionals

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution.

General

The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]

Ocular

Hypersensitivity

At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]

Other

Dermatologic

Sulfonamides:
Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).

Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]

Hematologic

Sulfonamides:
Frequency not reported: Agranulocytosis, aplastic anemia, other blood dyscrasias[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]

Hepatic

Sulfonamides:
Frequency not reported: Fulminant hepatic necrosis[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]

References

1. "Product Information. Sodium Sulamyd (sulfacetamide sodium ophthalmic)." Schering Corporation

2. Cerner Multum, Inc. "Australian Product Information."

More about Ocu-Sul 30 (sulfacetamide sodium ophthalmic)

Patient resources

Other brands

Bleph-10

Professional resources

Related treatment guides

Further information

Ocu-Sul 30 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.